Paratek: FDA panel meet on antibacterial pneumonia/skin infection med

TIME: 8:30 a.m.

EVENT: Health and Human Services Department (HHS); Food and Drug Administration(FDA) (F.R. Page 28850) holds a meeting of the Antimicrobial Drugs Advisory Committee to discuss new drug applications 209816, for omadacycline tablets, and 209817, for omadacycline injection, sponsored by Paratek Pharmaceuticals, Inc., for the treatment of community acquired bacterial pneumonia and acute bacterial skin and skin structure infections.

DATE: August 8, 2018

LOCATION: FDA White Oak Campus, 10903 New Hampshire Avenue, Building 31 Conference Center, Room 1503, Silver Spring, Md.

CONTACT: Lauren Tesh, 301-796-9001, AMDAC@fda.hhs.gov

https://bit.ly/2MYwit0